The main goal of this study is to test a virtual reality (VR) program, Survivors' Virtual Reality Survivorship Experience (SurviVRSE), designed to help Breast …

Breast CancerAnthracycline Related Cardiotoxicity in Breast CancerVirtual Reality+1 more

~Estimated

~$10 – $6,250

Virginia Commonwealth UniversityNCT07426913

Phase 1

Phase II Trial of Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction (CRI18-026)

Cardiomyopathy is a major complication of doxorubicin (DOX) chemotherapy, and 10-21% of breast cancer patients receiving DOX experience compromised cardiac fun…

Anthracycline Related Cardiotoxicity in Breast Cancer

~Estimated

~$10 – $6,250

Texas Tech University Health Sciences CenterNCT03934905